SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016733
Filing Date
2022-11-08
Accepted
2022-11-08 07:06:42
Documents
65
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vygr-20220930x10q.htm   iXBRL 10-Q 2323914
2 EX-31.1 vygr-20220930xex31d1.htm EX-31.1 13695
3 EX-31.2 vygr-20220930xex31d2.htm EX-31.2 13786
4 EX-32.1 vygr-20220930xex32d1.htm EX-32.1 10735
5 GRAPHIC vygr-20220930x10q006.jpg GRAPHIC 54086
6 GRAPHIC vygr-20220930x10q008.jpg GRAPHIC 24402
  Complete submission text file 0001558370-22-016733.txt   7893158

Data Files

Seq Description Document Type Size
7 EX-101.SCH vygr-20220930.xsd EX-101.SCH 51717
8 EX-101.CAL vygr-20220930_cal.xml EX-101.CAL 46106
9 EX-101.DEF vygr-20220930_def.xml EX-101.DEF 222925
10 EX-101.LAB vygr-20220930_lab.xml EX-101.LAB 413331
11 EX-101.PRE vygr-20220930_pre.xml EX-101.PRE 346886
59 EXTRACTED XBRL INSTANCE DOCUMENT vygr-20220930x10q_htm.xml XML 1262732
Mailing Address 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 64 SIDNEY STREET CAMBRIDGE MA 02139 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37625 | Film No.: 221367182
SIC: 2836 Biological Products, (No Diagnostic Substances)